M&A

With massive acquisitions in Florida and beyond, PACS Group is growing at a breakneck pace. But is its REIT-fueled, 'locally led' model a new paradigm for care or a risky bet?

As private equity swallows local businesses, one firm offers a different path: partnership over predation. Can this new model save the soul of service industries?

EzFill is betting on convenience with its new mobile car wash service, challenging a market being consolidated by private equity's brick-and-mortar playbook.

A $435M portfolio acquisition is more than a transaction; it's a market signal. We dissect how Scion Group's latest move caps a multi-billion dollar spree.

Aedifica's absorption of Cofinimmo wasn't just a deal; it was a strategic masterstroke. An inside look at how this merger creates a healthcare real estate titan.

With three new directors appointed, the AkzoNobel-Axalta merger moves closer to reality. This finalized board is designed to navigate a complex integration.

SmallRig's acquisition of Kelvin's lighting assets is more than a simple buyout; it’s a calculated move to build an end-to-end creative ecosystem.

EPTG's acquisition of JBI Technologies isn't just a merger; it's a strategic play for vertical dominance in the rapidly evolving hospitality tech market.

Samsung Biologics is raising KRW 3 trillion to buy a peptide specialist and build a mega-campus. It's a bold play that trades short-term dilution for long-term dominance.

AstroNova's move to go private via a buyout by Arcline Investment Management is more than a premium exit; it's a strategic play in the high-stakes world of mission-critical industrial technology.

A new insurance partnership reveals private equity's playbook for the benefits sector. Here's what it means for employers battling rising costs and complexity.

NewBold's acquisition of Spencer Technologies isn't just a business deal. It's the blueprint for a single-source solution to retail's biggest tech headaches.

CrossCountry Mortgage just spent $1.28 billion to control your loan from start to finish. Is this a new industry blueprint or a debt-fueled risk for homeowners?

With its 52nd straight dividend hike, UBSI signals stability. But a new 5% stock buyback hints at a bolder strategy for acquisitions in a consolidating market.

Golden State Dermatology's acquisition of a Colorado Springs practice signals a larger trend. Can physician-led networks scale without losing the patient-first ethos?

A small dealership acquisition in Lakeland reveals a national strategy. Spark Dealer Group is rolling up local OPE businesses, but can it scale without losing its soul?

As 76% of Canada's SME owners near retirement, a $2 trillion asset transfer looms. Can a new summit fix the fragmented system before it's too late?

With a veteran of growth from GMS at the helm and backed by Platinum Equity, CBX Solutions is poised for a major transformation in the building products space.

Avenzo Therapeutics' new CHRO hire is more than a personnel move; it's a critical piece of a master plan for a public debut and oncology market disruption.

H.B. Fuller’s board spurns a $1.2B offer for its building adhesives unit, setting up a clash over strategy, valuation, and deep operational integrity.